$ALT
Altimmune, Inc.

2016 Q4 Form 10-Q Financial Statement

#000114420416131743 Filed on November 04, 2016

View on sec.gov

Income Statement

Concept 2016 Q4 2016 Q3 2015 Q4
Revenue $1.080M $901.0K $1.270M
YoY Change -14.96% -22.32% -30.6%
Cost Of Revenue -$50.00K
YoY Change
Gross Profit $1.320M
YoY Change
Gross Profit Margin 103.94%
Selling, General & Admin $1.800M $3.290M $980.0K
YoY Change 83.67% 167.48% -62.6%
% of Gross Profit 74.24%
Research & Development $2.380M $2.401M $1.170M
YoY Change 103.42% 113.25% -34.64%
% of Gross Profit 88.64%
Depreciation & Amortization $20.00K $32.24K $30.00K
YoY Change -33.33% -7.91% -25.0%
% of Gross Profit 2.27%
Operating Expenses $4.180M $5.691M $2.180M
YoY Change 91.74% 102.2% -51.01%
Operating Profit -$5.512M -$4.790M -$940.5K
YoY Change 486.13% 188.78% -64.15%
Interest Expense -$10.00K $9.408K -$280.0K
YoY Change -96.43% -4.85% -2900.0%
% of Operating Profit
Other Income/Expense, Net $40.00K -$5.537K $0.00
YoY Change -101.59%
Pretax Income -$3.060M -$4.795M -$1.220M
YoY Change 150.82% 266.22% -53.44%
Income Tax $0.00 $15.44K $20.00K
% Of Pretax Income
Net Earnings $77.80M -$4.795M -$1.238M
YoY Change -6382.43% 261.95% -52.9%
Net Earnings / Revenue 7203.85% -532.17% -97.51%
Basic Earnings Per Share $1.16 $1.68 -$0.02
Diluted Earnings Per Share $1.15 $1.67 -$0.02
COMMON SHARES
Basic Shares Outstanding 66.73M shares 65.00M shares 64.45M shares
Diluted Shares Outstanding 65.81M shares

Balance Sheet

Concept 2016 Q4 2016 Q3 2015 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.900M $135.9M $15.60M
YoY Change -81.41% 681.03% -16.13%
Cash & Equivalents $2.876M $69.11M $15.57M
Short-Term Investments $66.80M $6.400M
Other Short-Term Assets $400.0K $500.0K $200.0K
YoY Change 100.0% 150.0% 0.0%
Inventory
Prepaid Expenses
Receivables $400.0K $1.600M $1.500M
Other Receivables $800.0K $0.00 $0.00
Total Short-Term Assets $4.487M $138.0M $17.23M
YoY Change -73.95% 656.55% -10.51%
LONG-TERM ASSETS
Property, Plant & Equipment $177.9K $153.8K $233.7K
YoY Change -23.89% -38.04% -28.26%
Goodwill $18.76M $2.348M $22.49M
YoY Change -16.61% 0.0% 857.85%
Intangibles $14.95M
YoY Change
Long-Term Investments
YoY Change
Other Assets $22.25K $0.00 $53.38K
YoY Change -58.32% -100.0% 0.0%
Total Long-Term Assets $33.91M $2.502M $2.636M
YoY Change 1186.77% -5.58% -3.38%
TOTAL ASSETS
Total Short-Term Assets $4.487M $138.0M $17.23M
Total Long-Term Assets $33.91M $2.502M $2.636M
Total Assets $38.40M $140.5M $19.86M
YoY Change 93.33% 572.57% -9.63%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.005M $614.5K $521.1K
YoY Change 284.79% 100.72% 33.14%
Accrued Expenses $2.973M $2.000M $1.600M
YoY Change 85.8% -4.76% 33.33%
Deferred Revenue
YoY Change
Short-Term Debt $500.0K $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00
YoY Change -100.0%
Total Short-Term Liabilities $5.471M $3.728M $2.179M
YoY Change 151.01% 56.61% -15.58%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $442.6K $427.1K $433.4K
YoY Change 2.12% -0.91% -12.11%
Total Long-Term Liabilities $442.6K $427.1K $433.4K
YoY Change 2.12% -0.91% -12.11%
TOTAL LIABILITIES
Total Short-Term Liabilities $5.471M $3.728M $2.179M
Total Long-Term Liabilities $442.6K $427.1K $433.4K
Total Liabilities $6.193M $4.156M $3.213M
YoY Change 92.73% 28.91% -13.25%
SHAREHOLDERS EQUITY
Retained Earnings -$31.26M -$107.7M -$223.7M
YoY Change -86.03% -51.61% 1.56%
Common Stock $692.00 $6.642K $6.438K
YoY Change -89.25% -100.0% -100.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $32.21M $136.4M $43.13M
YoY Change
Total Liabilities & Shareholders Equity $38.40M $140.5M $19.86M
YoY Change 93.33% 572.57% -9.63%

Cashflow Statement

Concept 2016 Q4 2016 Q3 2015 Q4
OPERATING ACTIVITIES
Net Income $77.80M -$4.795M -$1.238M
YoY Change -6382.43% 261.95% -52.9%
Depreciation, Depletion And Amortization $20.00K $32.24K $30.00K
YoY Change -33.33% -7.91% -25.0%
Cash From Operating Activities -$1.490M -$12.04M -$1.830M
YoY Change -18.58% 805.26% -48.01%
INVESTING ACTIVITIES
Capital Expenditures -$40.00K -$150.0K -$20.00K
YoY Change 100.0% 1400.0%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $0.00
YoY Change
Cash From Investing Activities -$40.00K -$150.0K -$20.00K
YoY Change 100.0% 1400.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -690.0K 5.230M 30.00K
YoY Change -2400.0% 1587.1% -98.82%
NET CHANGE
Cash From Operating Activities -1.490M -12.04M -1.830M
Cash From Investing Activities -40.00K -150.0K -20.00K
Cash From Financing Activities -690.0K 5.230M 30.00K
Net Change In Cash -2.220M -6.960M -1.820M
YoY Change 21.98% 575.73% 87.63%
FREE CASH FLOW
Cash From Operating Activities -$1.490M -$12.04M -$1.830M
Capital Expenditures -$40.00K -$150.0K -$20.00K
Free Cash Flow -$1.450M -$11.89M -$1.810M
YoY Change -19.89% 800.76% -48.58%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2016Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.67
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
121850860 USD
CY2015Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.02
CY2016Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
65001584 shares
CY2015Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
64187618 shares
CY2016Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
65814765 shares
CY2015Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
64187618 shares
us-gaap Contracts Revenue
ContractsRevenue
4110833 USD
us-gaap Contracts Revenue
ContractsRevenue
9374155 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3409005 USD
CY2015Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
CY2015Q4 us-gaap Unbilled Contracts Receivable
UnbilledContractsReceivable
963345 USD
CY2016Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
509857 USD
CY2015Q4 us-gaap Derivative Instruments And Hedges Liabilities
DerivativeInstrumentsAndHedgesLiabilities
16411 USD
CY2016Q3 us-gaap Common Stock Value
CommonStockValue
6642 USD
CY2016Q3 us-gaap Stockholders Equity
StockholdersEquity
136383040 USD
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
16649117 USD
CY2016Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
140538587 USD
CY2015Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
19862397 USD
CY2016Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-107671444 USD
CY2015Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-223724025 USD
CY2016Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-3989789 USD
CY2016Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
25186 USD
CY2015Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-9888 USD
CY2016Q3 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-352057 USD
CY2015Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
349217 USD
CY2016Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.68
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3962019 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6343426 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5246396 USD
us-gaap Restructuring Charges
RestructuringCharges
0 USD
us-gaap Restructuring Charges
RestructuringCharges
2519273 USD
us-gaap Depreciation
Depreciation
110371 USD
us-gaap Depreciation
Depreciation
108798 USD
us-gaap Operating Expenses
OperatingExpenses
9862802 USD
us-gaap Operating Expenses
OperatingExpenses
11836486 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-5751969 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-2462331 USD
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
25614 USD
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-48492 USD
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-642643 USD
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
577426 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
6400 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
6594 USD
CY2016Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
66728568 shares
CY2016Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
69106979 USD
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Trading Symbol
TradingSymbol
PIP
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
15569813 USD
CY2016Q3 us-gaap Billed Contract Receivables
BilledContractReceivables
665659 USD
CY2015Q4 us-gaap Billed Contract Receivables
BilledContractReceivables
511994 USD
CY2016Q3 us-gaap Unbilled Contracts Receivable
UnbilledContractsReceivable
912126 USD
CY2015Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
181714 USD
CY2015Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
433407 USD
CY2016Q3 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
0 USD
CY2016Q3 us-gaap Assets Current
AssetsCurrent
138036311 USD
CY2015Q4 us-gaap Assets Current
AssetsCurrent
17226866 USD
CY2015Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
491791 USD
CY2016Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
153823 USD
CY2016Q3 us-gaap Liabilities
Liabilities
4155547 USD
CY2015Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
233694 USD
CY2016Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
0 USD
CY2015Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
53384 USD
CY2016Q3 us-gaap Goodwill
Goodwill
2348453 USD
CY2015Q4 us-gaap Liabilities
Liabilities
3213280 USD
CY2015Q4 us-gaap Common Stock Value
CommonStockValue
6438 USD
CY2016Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
244035496 USD
CY2015Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
240366704 USD
CY2016Q3 us-gaap Contracts Revenue
ContractsRevenue
993885 USD
CY2015Q3 us-gaap Contracts Revenue
ContractsRevenue
1155839 USD
CY2015Q4 us-gaap Goodwill
Goodwill
2348453 USD
CY2016Q3 us-gaap Assets
Assets
140538587 USD
CY2015Q4 us-gaap Assets
Assets
19862397 USD
CY2016Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
614543 USD
CY2015Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
521122 USD
CY2016Q3 pip Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
1778193 USD
CY2015Q4 pip Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
1248708 USD
CY2016Q3 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
173301 USD
CY2015Q4 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
381950 USD
CY2016Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
11588 USD
CY2015Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
11250 USD
CY2016Q3 us-gaap Derivative Instruments And Hedges Liabilities
DerivativeInstrumentsAndHedgesLiabilities
1150845 USD
CY2016Q3 us-gaap Liabilities Current
LiabilitiesCurrent
3728470 USD
CY2015Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2179441 USD
CY2016Q3 us-gaap Restructuring Reserve Noncurrent
RestructuringReserveNoncurrent
0 USD
CY2015Q4 us-gaap Restructuring Reserve Noncurrent
RestructuringReserveNoncurrent
108641 USD
CY2016Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
427077 USD
CY2016Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1236692 USD
CY2015Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1125865 USD
CY2016Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3714747 USD
CY2015Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1231035 USD
CY2016Q3 us-gaap Restructuring Charges
RestructuringCharges
0 USD
CY2015Q3 us-gaap Restructuring Charges
RestructuringCharges
422482 USD
CY2016Q3 us-gaap Depreciation
Depreciation
32235 USD
CY2015Q3 us-gaap Depreciation
Depreciation
35005 USD
CY2016Q3 us-gaap Operating Expenses
OperatingExpenses
4983674 USD
CY2015Q3 us-gaap Operating Expenses
OperatingExpenses
2814387 USD
CY2015Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-1658548 USD
CY2015Q3 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
359796 USD
CY2016Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
659 USD
CY2015Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-691 USD
CY2016Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
113240239 USD
CY2016Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
109250450 USD
CY2015Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-1309331 USD
CY2016Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
15437 USD
CY2015Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
15437 USD
CY2016Q3 us-gaap Net Income Loss
NetIncomeLoss
109235013 USD
CY2015Q3 us-gaap Net Income Loss
NetIncomeLoss
-1324768 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
306336 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
116098891 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
0 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-2155995 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
46310 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
46310 USD
us-gaap Net Income Loss
NetIncomeLoss
116052581 USD
us-gaap Net Income Loss
NetIncomeLoss
-2202305 USD
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.79
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.79
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.03
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
64715647 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
63858500 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
65322158 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
63858500 shares
CY2016Q3 pip Otherincome Loss Foreign Currency Transaction And Translation Reclassification Adjustment Realized Upon Sale Or Liquidation
OtherincomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentRealizedUponSaleOrLiquidation
0 USD
CY2015Q3 pip Otherincome Loss Foreign Currency Transaction And Translation Reclassification Adjustment Realized Upon Sale Or Liquidation
OtherincomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentRealizedUponSaleOrLiquidation
0 USD
pip Otherincome Loss Foreign Currency Transaction And Translation Reclassification Adjustment Realized Upon Sale Or Liquidation
OtherincomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentRealizedUponSaleOrLiquidation
0 USD
pip Otherincome Loss Foreign Currency Transaction And Translation Reclassification Adjustment Realized Upon Sale Or Liquidation
OtherincomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentRealizedUponSaleOrLiquidation
229192 USD
CY2016Q3 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
113566451 USD
CY2015Q3 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
0 USD
us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
122461489 USD
us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
0 USD
CY2016Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
0 USD
CY2015Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
0 USD
CY2016Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
109247359 USD
CY2015Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1324768 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
336 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
116064927 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1972777 USD
CY2016Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Reclassification Adjustment From Aoci Realized Upon Sale Or Liquidation Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax
0 USD
CY2015Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Reclassification Adjustment From Aoci Realized Upon Sale Or Liquidation Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax
0 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Reclassification Adjustment From Aoci Realized Upon Sale Or Liquidation Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax
0 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Reclassification Adjustment From Aoci Realized Upon Sale Or Liquidation Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax
-229192 USD
us-gaap Share Based Compensation
ShareBasedCompensation
1896542 USD
us-gaap Share Based Compensation
ShareBasedCompensation
426988 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
46310 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
46310 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-13460 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
51820 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
687 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
7600 USD
us-gaap Increase Decrease In Unbilled Receivables
IncreaseDecreaseInUnbilledReceivables
-51219 USD
us-gaap Increase Decrease In Unbilled Receivables
IncreaseDecreaseInUnbilledReceivables
362232 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
328326 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
9602 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
93421 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-85175 USD
us-gaap Increase Decrease In Restructuring Reserve
IncreaseDecreaseInRestructuringReserve
-330750 USD
us-gaap Increase Decrease In Restructuring Reserve
IncreaseDecreaseInRestructuringReserve
800769 USD
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
479749 USD
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
149438 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
118644494 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-1387028 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
30500 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
1772454 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
7600 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-66877399 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-60677 USD
us-gaap Proceeds From Repayments Of Other Long Term Debt
ProceedsFromRepaymentsOfOtherLongTermDebt
0 USD
us-gaap Proceeds From Repayments Of Other Long Term Debt
ProceedsFromRepaymentsOfOtherLongTermDebt
-750007 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
687 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
68277 USD
CY2014Q3 pip Additional Fund Value
AdditionalFundValue
6000000 USD
CY2016Q3 pip Billed And Unbilled Accounts Receivable Net
BilledAndUnbilledAccountsReceivableNet
1600000 USD
pip Distribution Rate Of Cash Proceeds To Stock Holders
DistributionRateOfCashProceedsToStockHolders
0.9 pure
CY2015Q4 us-gaap Restructuring Reserve
RestructuringReserve
490591 USD
us-gaap Restructuring Reserve Settled Without Cash2
RestructuringReserveSettledWithoutCash2
131822 USD
us-gaap Restructuring Reserve Accrual Adjustment1
RestructuringReserveAccrualAdjustment1
185468 USD
CY2016Q3 us-gaap Restructuring Reserve
RestructuringReserve
173301 USD
pip Percentage Of Share Based Compensation Forfeitures
PercentageOfShareBasedCompensationForfeitures
0.12 pure
CY2016Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1547822 USD
CY2015Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
93757 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1896542 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
193594 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-2383 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
169 USD
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
18643351 USD
CY2015Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
17389409 USD
us-gaap Interest Paid
InterestPaid
0 USD
us-gaap Interest Paid
InterestPaid
108134 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
153665 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-110656 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1773343 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
943601 USD
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-889 USD
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
0 USD
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-53384 USD
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
0 USD
CY2014Q3 pip Total Value Of Contracts With Government
TotalValueOfContractsWithGovernment
28100000 USD
CY2014Q3 pip Initial Fund Value
InitialFundValue
5200000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
426988 USD
pip Share Based Compensation Extension Of Exercise Period
ShareBasedCompensationExtensionOfExercisePeriod
75000 USD
pip Share Based Compensation Reversal From Stock Option Forfeitures
ShareBasedCompensationReversalFromStockOptionForfeitures
129000 USD
pip Share Based Compensation Reversal Net
ShareBasedCompensationReversalNet
53741 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
112000 shares
pip Share Based Compensation Arrangement By Share Based Payment Award Restricted Stock Units Granted In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnitsGrantedInPeriod
117500 shares
CY2016Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
600000 USD
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y9M18D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
200000 shares
CY2016Q3 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
20000 USD
us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
50000 USD
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6000000 shares
CY2015Q4 us-gaap Litigation Settlement Interest
LitigationSettlementInterest
205000000 USD
CY2015Q1 us-gaap Loss Contingency Damages Awarded Value
LossContingencyDamagesAwardedValue
194600000 USD
CY2015Q1 us-gaap Loss Contingency Estimate Of Possible Loss
LossContingencyEstimateOfPossibleLoss
113100000 USD
CY2015Q1 us-gaap Litigation Settlement Expense
LitigationSettlementExpense
81500000 USD
CY2015Q4 us-gaap Government Contract Receivable Progess Payments Offset
GovernmentContractReceivableProgessPaymentsOffset
5800000 USD
CY2016Q2 us-gaap Government Contract Receivable Progess Payments Offset
GovernmentContractReceivableProgessPaymentsOffset
800000 USD
CY2016Q3 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
214147 USD
CY2016Q3 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
356911 USD
pip Operating Lease Term
OperatingLeaseTerm
P10Y
us-gaap Operating Leases Rent Expense Sublease Rentals1
OperatingLeasesRentExpenseSubleaseRentals1
100000 USD
CY2015Q4 pip Beneficial Ownership Percentage Held By Affiliates
BeneficialOwnershipPercentageHeldByAffiliates
0.0499 pure
CY2015Q4 pip Additional Amount To Declare Stockholder As Acquiring Person Percentage
AdditionalAmountToDeclareStockholderAsAcquiringPersonPercentage
0.005 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
186957 shares
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
1189214 shares
CY2016Q3 us-gaap Short Term Investments
ShortTermInvestments
66841690 USD
CY2015Q4 us-gaap Short Term Investments
ShortTermInvestments
0 USD
CY2016Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
1051358 shares
pip Percentage Of Share Based Compensation Forfeitures
PercentageOfShareBasedCompensationForfeitures
0.12 pure
CY2015Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6000000 shares
CY2016Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
12346 USD
CY2015Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
0 USD
CY2016Q3 us-gaap Available For Sale Securities Gross Unrealized Gains
AvailableForSaleSecuritiesGrossUnrealizedGains
12346 USD
us-gaap Available For Sale Securities Gross Unrealized Gains
AvailableForSaleSecuritiesGrossUnrealizedGains
12346 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
53537166 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-1253942 USD
CY2016Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2015Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2016Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2015Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2016Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
66423033 shares
CY2016Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
66423033 shares
CY2015Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
64382086 shares
CY2015Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
64382086 shares
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0 USD
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
36981 USD
CY2016Q3 us-gaap Legal Fees
LegalFees
1000000 USD
CY2015Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
100000 shares
CY2016Q3 us-gaap Derivative Liabilities
DerivativeLiabilities
1150845 USD
CY2016Q3 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
1051358 shares
CY2016Q3 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
831193 shares
CY2016Q3 us-gaap Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
805994 shares
us-gaap Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
852244 shares
CY2016Q3 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
571058 USD
pip Percentage Of Common Stock Delivered
PercentageOfCommonStockDelivered
1 pure
CY2015Q3 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
20000 USD
us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
50000 USD
CY2015Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
1922781 shares
us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
0 USD
pip Amortization Of Premium And Discount On Short Term Investments
AmortizationOfPremiumAndDiscountOnShortTermInvestments
-18242 USD
us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
66847586 USD
CY2015Q3 us-gaap Available For Sale Securities Gross Unrealized Gains
AvailableForSaleSecuritiesGrossUnrealizedGains
0 USD
us-gaap Available For Sale Securities Gross Unrealized Gains
AvailableForSaleSecuritiesGrossUnrealizedGains
0 USD
pip Amortization Of Premium And Discount On Short Term Investments
AmortizationOfPremiumAndDiscountOnShortTermInvestments
0 USD
CY2016Q3 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
62000000 USD
pip Class Of Warrant Or Right Outstanding Warrants Expired
ClassOfWarrantOrRightOutstandingWarrantsExpired
371423 shares
CY2016Q3 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
69106979 USD
CY2016Q3 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
135948669 USD
CY2016Q3 us-gaap Available For Sale Securities Short Term Investments Amortized Cost
AvailableForSaleSecuritiesShortTermInvestmentsAmortizedCost
66829344 USD
pip Cash And Cash Equivalents And Short Term Investments Amortized Cost
CashAndCashEquivalentsAndShortTermInvestmentsAmortizedCost
135936323 USD
CY2016Q3 pip Incremental Common Shares Attributable To Dilutive Effect Of Calloptions
IncrementalCommonSharesAttributableToDilutiveEffectOfCalloptions
454803 shares
CY2016Q3 pip Incremental Common Shares Attributable To Dilutive Effect Of Warrants
IncrementalCommonSharesAttributableToDilutiveEffectOfWarrants
358379 shares
pip Incremental Common Shares Attributable To Dilutive Effect Of Warrants
IncrementalCommonSharesAttributableToDilutiveEffectOfWarrants
224137 shares
pip Incremental Common Shares Attributable To Dilutive Effect Of Calloptions
IncrementalCommonSharesAttributableToDilutiveEffectOfCalloptions
382373 shares
CY2016Q3 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
0 USD
us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
0 USD
CY2016Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
109235013 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
116052581 USD
CY2016Q3 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Diluted
UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted
0 USD
us-gaap Undistributed Earnings Loss Allocated To Participating Securities Diluted
UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted
0 USD
CY2016Q3 pip Dilutive Securities Effect On Basic Earnings Per Share Change In Fair Value Of Dilutive Warrants
DilutiveSecuritiesEffectOnBasicEarningsPerShareChangeInFairValueOfDilutiveWarrants
352057 USD
pip Dilutive Securities Effect On Basic Earnings Per Share Change In Fair Value Of Dilutive Warrants
DilutiveSecuritiesEffectOnBasicEarningsPerShareChangeInFairValueOfDilutiveWarrants
642643 USD
CY2016Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
109587070 USD
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
116695224 USD
CY2016Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
805994 shares
CY2016Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
70000 shares
CY2015Q4 pip Class Of Warrant Or Right Outstanding Warrants Expired
ClassOfWarrantOrRightOutstandingWarrantsExpired
500000 shares
us-gaap Use Of Estimates
UseOfEstimates
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <i><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">Use of Estimates</font></i></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <i>&#160;</i></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Our unaudited condensed consolidated financial statements include significant estimates for our share-based compensation, deferred tax assets, liabilities and valuation allowances, and the value of our financial instruments, among other things. Because of the use of estimates inherent in the financial reporting process, actual results could differ significantly from those estimates.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>

Files In Submission

Name View Source Status
0001144204-16-131743-index-headers.html Edgar Link pending
0001144204-16-131743-index.html Edgar Link pending
0001144204-16-131743.txt Edgar Link pending
0001144204-16-131743-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
pip-20160930.xml Edgar Link completed
pip-20160930.xsd Edgar Link pending
pip-20160930_cal.xml Edgar Link unprocessable
pip-20160930_def.xml Edgar Link unprocessable
pip-20160930_lab.xml Edgar Link unprocessable
pip-20160930_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
v450986_10q.htm Edgar Link pending
v450986_ex31-1.htm Edgar Link pending
v450986_ex31-2.htm Edgar Link pending
v450986_ex32-1.htm Edgar Link pending
v450986_ex32-2.htm Edgar Link pending